Product Description: CLZX-205 (compound C-7) is a selective inhibitor of CDK9, with the IC50 of 2.9 nM. CLZX-205 plays an important role in cancer research[1].
Formula: C26H30N8O
References: [1]Ye Zhong, et al. Identification of a Novel Selective CDK9 Inhibitor for the Treatment of CRC: Design, Synthesis, and Biological Activity Evaluation. J Med Chem. 2024 Mar 28;67(6):4739-4756.
Molecular Weight: 470.57
Research Area: Cancer
Solubility: 10 mM in DMSO
Target: CDK